Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 2:11 PM
Ignite Modification Date:
2025-12-24 @ 2:11 PM
NCT ID:
NCT06986395
Eligibility Criteria:
Inclusion Criteria:
* Hospitalized patients aged ≥65 years
* Diagnosed with sarcopenia per EWGSOP2019 criteria
* Acute medical conditions stabilized for ≥4 weeks (e.g., resolved infections, controlled heart failure)
Exclusion Criteria:
* Severe disability (Barthel Index ≤40)
* Significant cognitive impairment (MMSE ≤18) or major psychiatric disorders (DSM-5 criteria)
* Contraindications to blood flow restriction training:
* History/predisposition to deep vein thrombosis
* Coagulopathy (INR \>1.5, platelets \<100×10⁹/L)
* Symptomatic varicose veins (CEAP class C4-C6)
* Uncontrolled hypertension (BP \>160/100 mmHg)
* Chronic lymphedema (ISL stage II-III)
* Peripheral artery disease (ABI ≤0.7)
* Active systemic infection (CRP \>10 mg/L)
* Malignancy (except non-melanoma skin cancer)
* Severe renal impairment (eGFR \<30 mL/min/1.73m²)
* Acute coronary syndrome within 3 months
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
65 Years
Maximum Age:
100 Years
Study:
NCT06986395
Study Brief:
Protocol Section:
NCT06986395